"Designing Growth Strategies is in our DNA"

Schizophrenia Drugs Market Size, Share & Industry Analysis, By Therapeutic Class (Second Generation, Third Generation, Others), By Treatment (Oral, Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others) and Regional Forecast, 2025-2032

Last Updated: June 30, 2025 | Format: PDF | Report ID: FBI101531

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Increasing Adoption of Long Acting Injectable (LAIs) as a Form of Treatment
    2. Prevalence of Schizophrenia Disorders by Key Regions
    3. New Product Launches
    4. Pipeline Analysis
    5. Regulatory Scenario By Key Regions
    6. Analysis of First Generation Antipsychotics versus Second & Third Generation Antipsychotics
    7. Overview of R&D Initiatives in Schizophrenia Treatment
  5. Global Schizophrenia Drugs Market Analysis, Insights and Forecast, 2019-2032
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Therapeutic Class
      1. Third Generation Antipsychotics
      2. Second Generation Antipsychotics
      3. Others
    3. Market Analysis, Insights and Forecast – By Treatment
      1. Oral
      2. Injectable
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    5. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Schizophrenia Drugs Market Analysis, Insights and Forecast, 2019-2032
    1. Key Findings / Summary
    2. Market Analysis – By Therapeutic Class
      1. Third Generation Antipsychotics
      2. Second Generation Antipsychotics
      3. Others
    3. Market Analysis – By Treatment
      1. Oral
      2. Injectable
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    5. Market Analysis – By Country
      1. U.S.
      2. Canada
  7. Europe Schizophrenia Drugs Market Analysis, Insights and Forecast, 2019-2032
    1. Key Findings / Summary
    2. Market Analysis – By Therapeutic Class
      1. Third Generation Antipsychotics
      2. Second Generation Antipsychotics
      3. Others
    3. Market Analysis – By Treatment
      1. Oral
      2. Injectable
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    5. Market Analysis – By Country/ Sub-Region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Schizophrenia Drugs Market Analysis, Insights and Forecast, 2019-2032
    1. Key Findings / Summary
    2. Market Analysis – By Therapeutic Class
      1. Third Generation Antipsychotics
      2. Second Generation Antipsychotics
      3. Others
    3. Market Analysis – By Treatment
      1. Oral
      2. Injectable
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    5. Market Analysis – By Country/ Sub-Region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Schizophrenia Drugs Market Analysis, Insights and Forecast, 2019-2032
    1. Key Findings / Summary
    2. Market Analysis – By Therapeutic Class
      1. Third Generation Antipsychotics
      2. Second Generation Antipsychotics
      3. Others
    3. Market Analysis – By Treatment
      1. Oral
      2. Injectable
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    5. Market Analysis – By Country/ Sub-Region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Schizophrenia Drugs Market Analysis, Insights and Forecast, 2019-2032
    1. Key Findings / Summary
    2. Market Analysis – By Therapeutic Class
      1. Third Generation Antipsychotics
      2. Second Generation Antipsychotics
      3. Others
    3. Market Analysis – By Treatment
      1. Oral
      2. Injectable
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    5. Market Analysis – By Country/ Sub-Region
      1. GCC Countries
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2024)
    3. Competition Dashboard
    4. Comparative Analysis – Major Players
    5. Company Profiles
      1. H. Lundbeck A/S
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability) 
      2. Otsuka Pharmaceutical Co., Ltd.
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. Janssen Pharmaceuticals, Inc.
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. Eli Lilly and Company
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. AstraZeneca
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. ALLERGAN
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. Vanda Pharmaceuticals Inc.
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      8. Sumitomo Dainippon Pharma Co., Ltd.
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      9. Alkermes plc
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      10. Bristol-Myers Squibb Company
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      11. Other Prominent Players
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
  12. Strategic Recommendations
Read Less

Figure 1:  Global Schizophrenia Drugs Market Revenue Breakdown (US$ Mn, %) by Region, 2024 & 2032

Figure 2:  Global Schizophrenia Drugs Market Value Share (%), by Therapeutic Class, 2024 & 2032

Figure 3:  Global Schizophrenia Drugs Market Forecast (US$ Mn), by Second Generation, 2019-2032

Figure 4:  Global Schizophrenia Drugs Market Forecast (US$ Mn), by Third Generation, 2019-2032

Figure 5:  Global Schizophrenia Drugs Market Forecast (US$ Mn), by Others, 2019-2032

Figure 6:  Global Schizophrenia Drugs Market Value Share (%), by Treatment, 2024 & 2032

Figure 7:  Global Schizophrenia Drugs Market Forecast (US$ Mn), by Oral, 2019-2032

Figure 8:  Global Schizophrenia Drugs Market Forecast (US$ Mn), by Injectable, 2019-2032

Figure 9:  Global Schizophrenia Drugs Market Value Share (%), by Distribution Channel, 2024 & 2032

Figure 10:  Global Schizophrenia Drugs Market Forecast (US$ Mn), by Hospital Pharmacies, 2019-2032

Figure 11:  Global Schizophrenia Drugs Market Forecast (US$ Mn), by Retail Pharmacies, 2019-2032

Figure 12:  Global Schizophrenia Drugs Market Forecast (US$ Mn), by Online Pharmacies, 2019-2032

Figure 13:  Global Schizophrenia Drugs Market Forecast (US$ Mn), by Others, 2019-2032

Figure 14:  Global Schizophrenia Drugs Market Value (US$ Mn), by Region, 2024 & 2032

Figure 15:  North America Schizophrenia Drugs Market Value (US$ Mn), by Therapeutic Class, 2024 & 2032

Figure 16:  North America Schizophrenia Drugs Market Value Share (%), by Therapeutic Class, 2024 

Figure 17:  North America Schizophrenia Drugs Market Value (US$ Mn), by Treatment, 2024 & 2032

Figure 18:  North America Schizophrenia Drugs Market Value Share (%), by Treatment, 2024

Figure 19:  North America Schizophrenia Drugs Market Value (US$ Mn), by Distribution Channel, 2024 & 2032

Figure 20:  North America Schizophrenia Drugs Market Value Share (%), by Distribution Channel, 2024

Figure 21:  North America Schizophrenia Drugs Market Value (US$ Mn), By Country, 2024 & 2032

Figure 22:  North America Schizophrenia Drugs Market Value Share (%), By Country, 2024 

Figure 23:  Europe Schizophrenia Drugs Market Value (US$ Mn), by Therapeutic Class, 2024 & 2032

Figure 24:  Europe Schizophrenia Drugs Market Value Share (%), by Therapeutic Class, 2024 

Figure 25:  Europe Schizophrenia Drugs Market Value (US$ Mn), by Treatment, 2024 & 2032

Figure 26:  Europe Schizophrenia Drugs Market Value Share (%), by Treatment, 2024 

Figure 27:  Europe Schizophrenia Drugs Market Value (US$ Mn), by Distribution Channel, 2024 & 2032

Figure 28:  Europe Schizophrenia Drugs Market Value Share (%), by Distribution Channel, 2024 

Figure 29:  Europe Schizophrenia Drugs Market Value (US$ Mn), By Country/ Sub-region, 2024 & 2032

Figure 30:  Europe Schizophrenia Drugs Market Value Share (%), By Country/ Sub-region, 2024 

Figure 31:  Asia Pacific Schizophrenia Drugs Market Value (US$ Mn), by Therapeutic Class, 2024 & 2032

Figure 32:  Asia Pacific Schizophrenia Drugs Market Value Share (%), by Therapeutic Class, 2024

Figure 33:  Asia Pacific Schizophrenia Drugs Market Value (US$ Mn), by Treatment, 2024 & 2032

Figure 34:  Asia Pacific Schizophrenia Drugs Market Value Share (%), by Treatment, 2024

Figure 35:  Asia Pacific Schizophrenia Drugs Market Value (US$ Mn), by Distribution Channel, 2024 & 2032

Figure 36:  Asia Pacific Schizophrenia Drugs Market Value Share (%), by Distribution Channel, 2024

Figure 37:  Asia Pacific Schizophrenia Drugs Market Value (US$ Mn), By Country/ Sub-region, 2024 & 2032

Figure 38:  Asia Pacific Schizophrenia Drugs Market Value Share (%), By Country/ Sub-region, 2024

Figure 39:  Latin America Schizophrenia Drugs Market Value (US$ Mn), by Therapeutic Class, 2024 & 2032

Figure 40:  Latin America Schizophrenia Drugs Market Value Share (%), by Therapeutic Class, 2024

Figure 41:  Latin America Schizophrenia Drugs Market Value (US$ Mn), by Treatment, 2024 & 2032

Figure 42:  Latin America Schizophrenia Drugs Market Value Share (%), by Treatment, 2024

Figure 43:  Latin America Schizophrenia Drugs Market Value (US$ Mn), by Distribution Channel, 2024 & 2032

Figure 44:  Latin America Schizophrenia Drugs Market Value Share (%), by Distribution Channel, 2024

Figure 45:  Latin America Schizophrenia Drugs Market Value (US$ Mn), By Country/ Sub-region, 2024 & 2032

Figure 46:  Latin America Schizophrenia Drugs Market Value Share (%), By Country/ Sub-region, 2024

Figure 47:  Middle East & Africa Schizophrenia Drugs Market Value (US$ Mn), by Therapeutic Class, 2024 & 2032

Figure 48:  Middle East & Africa Schizophrenia Drugs Market Value Share (%), by Therapeutic Class, 2024

Figure 49:  Middle East & Africa Schizophrenia Drugs Market Value (US$ Mn), by Treatment, 2024 & 2032

Figure 50:  Middle East & Africa Schizophrenia Drugs Market Value Share (%), by Treatment, 2024

Figure 51:  Middle East & Africa Schizophrenia Drugs Market Value (US$ Mn), by Distribution Channel, 2024 & 2032

Figure 52:  Middle East & Africa Schizophrenia Drugs Market Value Share (%), by Distribution Channel, 2024

Figure 53:  Middle East & Africa Schizophrenia Drugs Market Value (US$ Mn), By Country/ Sub-region, 2024 & 2032

Figure 54:  Middle East & Africa Schizophrenia Drugs Market Value Share (%), By Country/ Sub-region, 2024

Figure 55:  Global Schizophrenia Drugs Market Share (%), By Company, 2024

 

Table 1:  Global Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Therapeutic Class, 2019–2032

Table 2:  Global Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Treatment, 2019–2032

Table 3:  Global Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2019–2032

Table 4:  Global Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Region, 2019-2032

Table 5:  North America Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Therapeutic Class, 2019-2032

Table 6:  North America Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Treatment, 2019-2032

Table 7:  North America Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2019-2032

Table 8:  North America Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, By Country, 2019-2032

Table 9:  Europe Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Therapeutic Class, 2019-2032

Table 10:  Europe Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Treatment, 2019-2032

Table 11:  Europe Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2019-2032

Table 12:  Europe Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2019-2032

Table 13:  Asia Pacific Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Therapeutic Class, 2019-2032

Table 14:  Asia Pacific Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Treatment, 2019-2032

Table 15:  Asia Pacific Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2019-2032

Table 16:  Asia Pacific Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2019-2032

Table 17:  Latin America Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Therapeutic Class, 2019-2032

Table 18:  Latin America Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Treatment, 2019-2032

Table 19:  Latin America Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2019-2032

Table 20:  Latin America Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2019-2032

Table 21:  Middle East & Africa Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Therapeutic Class, 2019-2032

Table 22:  Middle East & Africa Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Treatment, 2019-2032

Table 23:  Middle East & Africa Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2019-2032

Table 24:  Middle East & Africa Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2019-2032

  • 2019-2032
  • 2024
  • 2019-2023
  • 134
GET A FREE SAMPLE

    man icon
    Mail icon
Consulting Services
    How will you benefit from our consulting services ?